IDE Cybersecurity

FDA Investigational Device Exemption (IDE) submissions sit on a 30-day review clock and are evaluated under 21 CFR Part 812. Section 524B and the 2026 premarket cybersecurity guidance still apply, and inadequate cybersecurity evidence can trigger a Clinical Hold under 21 CFR 812.42 that stops enrollment until concerns are resolved. This hub pulls together the services, guides, standards, and FAQs that explain what an IDE-scoped cybersecurity package looks like - and how to build it so the artifacts roll forward into the eventual 510(k), De Novo, or PMA.

Services

• Full-Service FDA Premarket Cybersecurity

  Full-service, end-to-end: we deliver 100% of the artifacts FDA reviewers expect for 510(k), De Novo, PMA, and IDE submissions - traceable, complete, and aligned with current 524B guidance.

• Medical Device Threat Modeling

  Comprehensive threat modeling per FDA Section V.A.1 - covering supply chain, deployment, environment of use, and decommission risks for the full device system.

• Medical Device Penetration Testing

  Hardware, firmware, mobile, and cloud - tested by operators with both red-team and medical-device experience. Reports built for FDA reviewers.

• FDA-Compliant SBOM Services

  Machine- and human-readable SBOMs with NTIA minimum elements, vulnerability mapping, and end-of-support tracking - built for FDA review.

In-depth guides

• 12 Critical Threat-Modeling Gaps in SubmissionsA practical, ungated guide to the threat modeling gaps that trigger FDA cybersecurity questions in 510(k), De Novo, and PMA submissions - and exactly how to close them before reviewers find them.
• The SPDF PlaybookA practical, ungated guide to building a Secure Product Development Framework (SPDF) that FDA accepts — the eight pillars, the artifacts each one produces, and a pre-submission readiness checklist you can score yourself against.
• The MedTech Cybersecurity Standards DecoderA plain-English field guide to FDA Section 524B, IEC 81001-5-1, AAMI TIR57, ANSI/AAMI SW96, ISO 14971, and 8 more medical device cybersecurity standards — what they require, how they connect, and what FDA expects in your eSTAR premarket submission.

Standards & guidance

Defined entries from our MedTech Cybersecurity Standards Glossary.

• FDA 2026 GuidanceFDA Premarket Cybersecurity Guidance (Feb 3, 2026)The FDA's final premarket cybersecurity guidance, effective February 3, 2026. Defines the seven-section cybersecurity submission format reviewers now enforce at Technical Screening, replacing the 2023 draft. Operationalizes Section 524B of the FD&C Act.
• Section 524BFD&C Act Cyber Device RequirementsAdded by the Consolidated Appropriations Act, 2023, Section 524B gives the FDA explicit authority to require a complete cybersecurity package in every premarket submission for a cyber device, and to refuse submissions that lack one.
• ANSI/AAMI SW96Medical Device Security Risk ManagementThe consensus standard for medical device security risk management - asset, threat, vulnerability, likelihood, severity, and residual risk acceptability.
• AAMI TIR57Principles for Medical Device Security – Risk ManagementThe MedTech-specific extension of ISO 14971 for cybersecurity. Defines how to identify cybersecurity assets, threats, and vulnerabilities, then estimate, evaluate, and control the resulting risk.
• ISO 14971Medical Device Risk ManagementThe umbrella risk-management standard for medical devices. Defines hazard identification, risk estimation, risk evaluation, risk control, and residual risk evaluation. Cybersecurity risks must be reconciled here so a security control never silently introduces a safety hazard.
• SPDFSecure Product Development FrameworkA documented framework that shows security activities are integrated across the device lifecycle - not bolted on at the end. Includes secure requirements, threat modeling, secure coding, V&V, vulnerability management, and post-market response.

From the blog

• Threat Modeling Connected & Implantable DevicesIf you're asking how to conduct a cybersecurity threat model for a connected or implantable medical device, the first thing to understand is that this is not the same exercise as modeling a web application or enterprise network. The stakes are categorically different. A missed attack vector on a hos
• Medical Device Safety vs Security RisksExplore the critical distinctions between safety and security risks in medical devices.
• Cybersecurity Best Practices for Medical Device DesignDiscover cybersecurity best practices for medical device design, from threat modeling to FDA-aligned lifecycle management, to protect patients and data.

Related FDA deficiencies

The deficiency letters reviewers most often write on submissions in this topic area. Each links to the full response playbook.

• Missing Security Architecture Views

  Your submission is missing one or more of the architecture views FDA 2026 expects (global system, multi-patient, updateability).

  Response playbook
• Insufficient Penetration Testing Evidence

  Reviewers find your penetration test scope too narrow, methodology unclear, or testers insufficiently independent.

  Response playbook
• Insufficient Secure Boot Evidence

  Reviewers want test evidence that secure boot, signed updates, and root-of-trust controls function as claimed.

  Response playbook
• Incomplete Threat Model

  Reviewers say your STRIDE/attack-tree analysis misses interfaces, trust boundaries, or post-market threat surfaces.

  Response playbook

Get FDA cleared without the cybersecurity headaches.

30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ submissions.